Researchers from MIT have teamed up with those from University of California at San Diego (UCSD), including IMES member Jeff Hasty, to engineer probiotics for detecting cancers that metastasize to the liver. The researchers have programmed E. coli strains that colonize the liver to emit a signal, that can be picked up with a urine test, if tumors in the liver are detected. Source: MIT .
